Methods and apparatus for a remote, noninvasive technique to detect chronic wasting disease (CWD) and similar diseases in live subjects

• US 20040154550A1
• Filed: 01/08/2004
• Published: 08/12/2004
• Est. Priority Date: 01/08/2003
• Status: Abandoned Application

• Current Assignee: Gary L. Mcquilkin
• Original Assignee: Gary L. Mcquilkin
• Inventors: McQuilkin, Gary L.
• Application Number:
  US10/753,981
• Publication Number:
  US 20040154550A1
• Time in Patent Office: Days
• US Class Current: 119/174
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/015 By temperature mapping of body part
• CPC Class Codes: A61B 5/4023 Evaluating sense of balance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/4519 Muscles A61B5/389, A61B5/224 take precedence

Abstract

This invention is directed to an approach for noninvasively and remotely screening live animals for chronic wasting disease (CWD) via the processing of thermal and/or visible spectrum images. The image processing takes advantage of the anatomical observation that the prions and vacuoles associated with CWD first accumulate in a region of the brainstem, called the obex, which is strategically surrounded by the nuclei of the twelve cranial nerves. Using the cranial nerves as ‘implanted’ sensors, the sensitive image processing algorithms of this invention detect physiological indications of cranial nerve degradation indicating the presence and progression of the disease.

Unlike brainstem dissection, tonsil biopsy or blood tests, this live animal test may be administered from a distance making it well suited for testing anesthetized animals, penned animals or even wild animals ranging in a field or forest habitat. As thermal camera and digital camera technologies continue to improve, the diagnostic distance is limited only by lens and resolution constraints.

While described initially for CWD diagnostics, this invention has application to other diseases which have impact on the cranial nerves. By empirically determining disease-specific and species-specific algorithm coefficients, additional applications may include additional transmissible spongiform encephalopathy (TSE) diseases such as scrapie, mad-cow disease, or Creutzfeldt-Jakob disease. This invention may also be applied to numerous other diseases which impact cranial or facial nerves such as West Nile Virus, Bell'"'"'s Palsy, Horner'"'"'s Syndrome, and Parkinson'"'"'s disease.

Claims

1. A method of noninvasively and/or remotely testing a live animal for a transmissible spongiform encephalopathy (TSE) disease such as chronic wasting disease (CWD) or mad cow disease, comprising:

taking a thermal image of the live animal; and

processing the thermal image to determine the presence of a TSE disease such as chronic wasting disease or mad cow disease.

2. A method as recited in claim 1, wherein taking the thermal image includes taking the thermal image from a distance of 15 feet or less from the live animal;

3. A method as recited in claim 1, wherein taking the thermal image includes taking the thermal image from a distance of greater than 15 feet from the live animal;

4. A method as recited in claim 1, wherein taking the thermal image includes taking the thermal image using a thermal camera located on an airborne platform.

5. A method of noninvasively and/or remotely testing a live animal for a transmissible spongiform encephalopathy (TSE) disease such as chronic wasting disease (CWD) or mad cow disease, comprising:

taking a visible spectrum image of the live animal; and

processing visible spectrum image to determine the presence of a TSE disease such as chronic wasting disease or mad cow disease.

6. A method as recited in claim 5, wherein taking the visible spectrum image includes taking the visible spectrum image from a distance of 15 feet or less from the live animal.

7. A method as recited in claim 5, wherein taking the visible spectrum image includes taking the visible spectrum image from a distance of greater than 15 feet from the live animal;

8. A method as recited in claim 5, wherein taking the visible spectrum image includes taking the visible spectrum image using a visible spectrum camera located on an airborne platform.

9. A method of noninvasively and/or remotely testing a live human subject for a transmissible spongiform encephalopathy (TSE) disease such as Creutzfelt-Jakob disease or mad cow disease, comprising:

taking a thermal image of the live human subject; and

processing the thermal image to determine the presence of a TSE disease such as Creutzfelt-Jakob disease or mad cow disease.

10. A method as recited in claim 9, wherein taking the thermal image includes taking the thermal image from a distance of 15 feet or less from the live human subject;

11. A method as recited in claim 9, wherein taking the thermal image includes taking the thermal image from a distance of greater than 15 feet from the live human subject;

12. A method of noninvasively and/or remotely testing a live human subject for a transmissible spongiform encephalopathy (TSE) disease such as Creutzfelt-Jakob disease or mad cow disease, comprising:

taking a visible spectrum image of the live human subject; and

processing visible spectrum image to determine the presence of a TSE disease such as Creutzfelt-Jakob disease or mad cow disease.

13. A method as recited in claim 12, wherein taking the visible spectrum image includes taking the visible spectrum image from a distance of 15 feet or less from the live human subject.

14. A method as recited in claim 12, wherein taking the visible spectrum image includes taking the visible spectrum image from a distance of greater than 15 feet from the live human subject;

15. A method of noninvasively and/or remotely testing a live animal or live human for a disease that affects one or more cranial nerve(s), comprising

taking at least one of a thermal image and a visible spectrum image of the live animal or human;

and

processing the at least one of a thermal image and the visible spectrum to determine the presence of the disease that affects cranial nerves.

16. A method recited in claim 15, wherein the disease is a transmissible spongiform encephalopathy disease (TSE) or a variant thereof.

17. A method recited in claim 15, wherein the disease is at least one of CWD, scrapie, mad cow disease, Creutzfelt-Jakob disease, West Nile virus, Bell'"'"'s Palsy, Horner'"'"'s Syndrome, and Parkinson'"'"'s disease, or a variant thereof.

18. A method of tracking progress of a disease that affects cranial nerves in a live animal or human, comprising:

taking a first image set comprising a first thermal image and/or a first visible spectrum image of the live animal or human;

taking at least a second set comprising a second thermal image and/or a second visible spectrum image of the live animal or human;

comparing information from the second image set to information from the first image set and determining progress of the disease.

19. A method recited in claim 18, wherein the disease is a transmissible spongiform encephalopathy disease (TSE) or a variant thereof.

20. A method recited in claim 18, wherein the disease is at least one of CWD, scrapie, mad cow disease, Creutzfelt-Jakob disease, West Nile virus, Bell'"'"'s Palsy, Horner'"'"'s Syndrome, and Parkinson'"'"'s disease, or a variant thereof.

21. A method as recited in claim 18, further comprising using the information from the first and second image sets to calculate a degradation score for individual cranial nerves.

22. A method as recited in claim 18, further comprising using the information from the first and second image sets to calculate a degradation score for grouped cranial nerves.

23. A method as recited in claim 18, further comprising tracking the vacuolization of the brainstem of the live animal or human by tracking the progress of the degradation of cranial nerve functions in conjunction with the 3D, anatomical positions of the cranial nerve nuclei in the brainstem.